Apoptotic effect of synthetic 2′,4′,5′-trimethoxychalcones in human K562 and Jurkat leukemia cells

Medicinal Chemistry Research

Volumn 23, Issue 10, 2014, Pages 4301-4319

  Costa, Aline ^a   Chiaradia Delatorre, Louise Domeneghini ^a   Dos Santos Bubniak, Lorena ^a   Mascarello, Alessandra ^a   Marzarotto, Marley Aparecida Licínio ^a   De Moraes, Ana Carolina Rabello ^a   Stumpf, Taisa Regina ^a   Cordeiro, Marlon Norberto Sechini ^a   Yunes, Rosendo Augusto ^a   Nunes, Ricardo José ^a   Santos Silva, Maria Cláudia ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Apoptotic effect; Cytotoxicity; Jurkat cells; K562 cells; Leukemia; Trimethoxychalcones

Indexed keywords

2',4',5' TRIMETHOXYCHALCONE DERIVATIVE; ANTINEOPLASTIC AGENT; CASPASE 3; CHALCONE DERIVATIVE; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IC50; JURKAT CELL LINE; JURKAT LEUKEMIA CELL; K562 CELL LINE; PROTEIN EXPRESSION;

EID: 85027931593     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-014-1002-4     Document Type: Article

References (43)

1. Anjaneyulu ASR, Murthy YLN (1994) Synthesis and characterization of some new chalcones and flavanones. Indian J Heterocycl Chem 4(1):9-14
2. Anjaneyulu ASR, Rani GS, Annapurna K.G., Mallavadhani UV, Murthy YLN (1995) Synthesis and characterization of some new oxygen and nitrogen heterocyclics: part II - 3,5-diarylisoxazoles, pyrazoles and 4,6-diarylpyrimidines. Indian J Chem Sect B 34(11): 933-938
3. Bello ML, Chiaradia LD, Dias LRS, Pacheco LK, Stumpf T.R., Mascarello A., Steindel M, Yunes RA, Castro H.C., Nunes RJ, Rangel CR (2011) Trimethoxy-chalcone derivatives inhibit growth of Leishmania braziliensis: synthesis, biological evaluation, molecular modeling and structure activity relationship (SAR). Bioorg Med Chem 19(16):5046-5052
4. Borchhardt DM, Mascarello A, Chiaradia L.D., Nunes RJ, Oliva G, Yunes RA, Andricopulo A.D. (2010) Biochemical evaluation of a series of synthetic chalcone and hydrazide derivatives as novel inhibitors of cruzain from Trypanosoma cruzi. J Braz Chem Soc 21(1):142-150
5. Calixto JB, Yunes RA, Neto ASO, Valle RMR, Rae G.A. (1984) Antispasmodic effects of an alkaloid extrated from Phyllanthus sellowianus: a comparative study with papaverine. Braz J Med Biol Res 17(3-4):313-321
6. Cory S, Adams J.M. (2002) The Bcl-2 family: regulators of the cellular life-or-death switch. Nat Rev 2:647-656
7. Cos P, Rajan P, Vedernikova I., Calomme M, Pieters L, Vlietinck A.J., Augustyns K., Haemers A, Vanden-Berghe D (2002) In vitro antioxidant profile of phenolic acid derivatives. Free Radic Res 36:711-716
8. Deng J, Sanchez T, Al-Mawsawi LQ, Dayam R., Yunes RA, Garofalo A, Bolger MB, Neamati N. (2007) Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore. Bioorg Med Chem 15(14):4985-5002
9. Dimmock JR, Elias DW, Beazely M.A., Kandepu N.M. (1999) Bioactivities of chalcones. Curr Med Chem 6(12):1125-1149
10. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495-516
11. Engeland MV, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CPM (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31(1):1-9
12. Frenzel A, Grespi F, Chmelewskij W., Villunger A. (2009) Bcl-2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis 14(4):584-596
13. Ghobrial IM, Witzig TE, Adjei A.A. (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55:178-194
14. Högberg T., Bengtsson S, de Paulis T, Johansson L, Ström P, Hall H., Ögren SO (1990) Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds. J Med Chem 33(4):1155-1163
15. Hsu YL, Kuo PL, Tzeng W.S., Lin C.C. (2006) Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis. Food Chem Toxicol 44(5):704-713
16. Hunter AM, Lacasse EC, Korneluk R.G. (2007) The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12:1543-1568
17. Kastan MB, Onyekwere O, Sisransky D., Vogelstein B, Craig R. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311
18. Lawrence NJ, Patterson RP, Ooi L.L., Cook D., Ducki S. (2006) Effects of alpha-substitutions on structure and biological activity of anticancer chalcones. Bioorg Med Chem 16(22):5844-5848
19. Leist M, Nicotera P. (1997) The shape of cell death. Biochem Biophys Res Commun 236(1):1-9
20. Levine AJ (1997) P53, the cellular gatekeeper for growth and division. Cell 88:323-331
21. Liu X, Go M. (2006) Antiproliferative properties of piperidinylchalcones. Bioorg Med Chem 14(1):153-163
22. Lodish H, Berk A, Zipursky S.L., Matsudaira P., Baltimore D, Darnrll J.E. (2000) Molecular cell biology, 4th edn. W. H. Freeman, New York
23. Maioral MF, Gaspar PC, Souza GRR, Mascarello A, Chiaradia L.D., Licínio MA, Moraes ACR, Yunes RA, Nunes RJ, Santos-Silva MC (2012) Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines. Biochimie 95(4):866-874
24. Nakayama K, Kamihira S. (2002) Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology. Leuk Lymphoma 43(12):2249-2255
25. Ni L, Meng QM, Siroski J.A. (2004) Recent advances in therapeutic chalcones. Expert Opin Ther Pat 14(12):1669-1691
26. Nowakowska ZA (2007) A review of anti-infective and antiinflammatory chalcones. Eur J Med Chem 42(2):125-137
27. Pedrini FS, Chiaradia LD, Licínio MA, Moraes ACR, Curta JC, Costa A, Mascarello A., Creczinsky-Pasa TB, Nunes RJ, Yunes R.A., Santos-Silva MC (2010) Induction of apoptosis and cell cycle arrest in L-1210 murine lymphoblastic leukaemia cells by (2E)- 3-(2-naphthyl)-1-(3'-methoxy-4'-hydroxy-phenyl)-2-propen-1one. J Pharm Pharmacol 62(9):1128-1136
28. Rao YK, Fang SH, Tzeng Y.M. (2004) Differential effects of synthesized 2'-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution. Bioorg Med Chem 12(10):2679-2686
29. Reigrodski J, Tambor J. (1910) Synthese des 2,3-dioxy-flavons. Ber Dtsch Chem Ges 43(2):1964-1968
30. Renvoizé C, Biola A, Pallardy M, Breard J (1998) Apoptosis: identification of dying cells. Cell Biol Toxicol 149(2):111-120
31. Romagnoli R, Baraldi PG, Carrion M.D., Cara CL, Cruz-Lopez O, Preti D, Tolomeo M., Grimaudo S, Di Cristina A, Zonta N, Balzarini J., Brancale A, Sarkar T, Hamel E (2008) Design, synthesis, and biological evaluation of tiophene analogues of chalcones. Bioorg Med Chem 16:5367-5376
32. Ruvolo PP, Deng X, May W.S. (2001) Phosphorylation of Bcl-2 and regulation of apoptosis. Leukemia 15(4):515-522
33. Sakai T, Eskander RN, Guo Y, Kim K.J., Mefford J., Hopkins J, Bhatia NN, Zi X, Hoang B.H. (2011) Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines. J Orthop Res 30(7):1045-1050
34. Saydam G, Aydin HH, Sahin F, Kucukoglu O., Erciyas E, Terzioglu E, Buyukkececi F., Omay S.B. (2003) Cytotoxic and inhibitory effects of 4,4'-dihydroxychalcone (RVC-588) on proliferation of human leukemic HL-60 cells. Leukemia Res 27(1):57-64
35. Scholzen T, Gerdes J. (2000) The Ki-67 Protein: from the known and the unknown. J Cell Physiol 182(3):311-322
36. Shen KH, Chang JK, Hsu Y.L., Kuo P.L. (2007) Chalcone arrests cell cycle progression and induces apoptosis through induction of mitochondrial pathway and inhibition of nuclear factor kappa B signalling in human bladder cancer cells. Basic Clin Pharmacol Toxicol 101(4):254-261
37. Van De Loosdrecht AA, Nennie E, Ossenkoppele G.J., Beelen RH, Langenhuijsen M.M. (1991) Cell mediated cytotoxicity against U937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. J Immunol Methods: 141:15-22
38. Vermeulen K, Bockstaele DRV, Berneman Z.N. (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36(3):131-149
39. Winter E, Chiaradia LD, Cordova CAS, Nunes RJ, Yunes R.A., Creczynski-Pasa TB (2010) Naphthylchalcones induce apoptosis and caspase activation in a leukemia cell line: the relationship between mitochondrial damage, oxidative stress, and cell death. Bioorg Med Chem 18:8026-8034
40. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556
41. Ye CL, Qian F, Wei D.Z., Lu YH, Liu J.W. (2005) Induction of apoptosis in K562 human leukemia cells by 2',4'-dihydroxy-6'-methoxy-3', 5'-dimethylchalcone. Leukemia Res 29(8):887-892
42. Zaffaroni N, Pennati M, Daidone M.G. (2005) Survivin as a target for new anticancer interventions. J Cell Mol Med 9(2):360-372
43. Zhivotovsky B, Orrenius S. (2003) Defects in the apoptotic machinery of cancer cells: role in drug resistance. Semin Cancer Biol 13(2):125-134